Preparation of bacterial cytoplasmic fractions.
Cells were grown in YT2x (0.1% glucose, 50 µg/mL kanamycin). Upon reaching OD600, 0.65, arabinose (0.2% final concentration) was added and after 2 h the cells were harvested by centrifugation at 6000 rpm (20 min, 4 °C). Pellets were resuspended in PBS (0.05% Triton X-100, 150 mM NaCl pH 7.4) and cells disrupted by two freeze-thaw cycles and three 30-second sonication cycles. Cell debris was removed by centrifugation at 12000 rpm (20 min, 4 °C).
Protein content of the supernatant was determined by Pierce™ BCA protein assay kit following the manufacturer's protocol.
IC50 determination
The inhibitory activity of clavulanic acid against FLC-1 fraction was assessed using nitrocefin as substrate. On a polystyrene 96-well plate and using the assay buffer described above, FLC-1 fraction (2 µg/mL) was incubated with clavulanic acid ranging from 1000 to 0.004 µM for 15 min at 25 °C. Nitrocefin with the concentration corresponding to Km value (44 µM) was added to all the wells and absorption at 492 nm was monitored over 30 scan cycles. The initial velocity data was normalized using nitrocefin with enzyme in the absence of inhibitor as 100% activity and nitrocefin in the absence of enzyme as 0% activity. IC50 curve-fitting was performed on Log(concentration) vs. Activity (%) data using GraphPad Prism 7 software. 
